Short Bartie Wendy, Bristol Myers Squibb’s EVP of Corporate Affairs, exercised Options for 1,236 shares at $66.92 per share on Sep. 1, 2026. The transaction matters to investors because her reported holdings changed to 12,684 shares, while her derivative-security balance fell to zero after the exercise.
Key Highlights
- Short Bartie Wendy reported ownership of 13,317 Bristol Myers Squibb shares after exercising the options.
- The executive forfeited 633 Bristol Myers Squibb shares at $66.92 per share.
- Her reported holding of Bristol Myers Squibb derivative securities was zero after the exercise.
Short Bartie Wendy, executive vice president of corporate affairs at Bristol Myers Squibb Co (NYSE: BMY), exercised options for 1,236 shares at $66.92 per share on Sep. 1, 2026. The transaction involved Bristol Myers Squibb shares and derivative securities. It also included a separate forfeiture of 633 shares at the same per-share price.
$66.92 Option Exercise Recorded on Sep.
1 Following the option exercise, Wendy reported ownership of 13,317 Bristol Myers Squibb shares. Following the separate forfeiture, she reported ownership of 12,684 shares. Both the exercise and forfeiture were recorded on Sep. 1, 2026, with the option exercise covering 1,236 derivative securities. Wendy’s reported derivative-security ownership was zero after the exercise. Short Bartie Wendy is identified in the filing as Bristol Myers Squibb’s EVP of Corporate Affairs.
FAQs
Q: What did Short Bartie Wendy do in the Bristol Myers Squibb transaction?
A: Short Bartie Wendy exercised options for 1,236 Bristol Myers Squibb shares at $66.92 per share on Sep. 1, 2026. The filing identifies the transaction as SEC transaction code M.
Q: How many Bristol Myers Squibb shares did Wendy own afterward?
A: Following the transaction, Short Bartie Wendy reported ownership of 12,684 Bristol Myers Squibb shares. The filing also records that she forfeited 633 shares at $66.92 per share.
Q: What happened to Wendy’s Bristol Myers Squibb derivative securities?
A: Short Bartie Wendy exercised options for 1,236 Bristol Myers Squibb derivative securities on Sep. 1, 2026. Following that transaction, her reported ownership of derivative securities was zero.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.